Serum MBP immunoreactivity and immunoglobulin level as markers of tumour type
| Autor: | D. G. T. Thomas, P A Seeldrayers, N R Hoyle |
|---|---|
| Rok vydání: | 1984 |
| Předmět: |
Adult
Male Cancer Research medicine.medical_specialty Pathology Neurology Immunoglobulin levels Central nervous system Radioimmunoassay Immunoglobulins Glioma medicine Humans Tumor type Spinal Cord Neoplasms biology Brain Neoplasms Myelin Basic Protein Complement C3 medicine.disease Myelin basic protein medicine.anatomical_structure Oncology biology.protein Female Neurology (clinical) Antibody |
| Zdroj: | Journal of neuro-oncology. 2(2) |
| ISSN: | 0167-594X |
| Popis: | Forty three patients, admitted to the department of Neurological Surgery for management of central nervous system tumours, were studied pre-operatively for serum myelin basic protein immunoreactivity as a marker of central nervous system lesion and for circulating immunoglobulins and complement (C3) levels. Myelin basic protein concentration did not appear to correlate with tumour type or grade. Serum immunoglobulin levels were found to be within the normal range but the mean IgM level was significantly higher in the glioma group when compared with meningiomas. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink